Methylxanthines, purine alkaloids found in plants, are found in beverages (coffee, tea, cocoa) and foods (chocolate and other cocoa-containing foods) commonly consumed worldwide. Members of this family include caffeine, theophylline and theobromine. Methylxanthines have a variety of pharmacological effects, and caffeine and theophylline are used as pharmaceuticals. Methylxanthines are metabolized in the liver predominantly by the enzyme CYP1A2. Their co-administration with CYP1A2 inhibitors may lead to pharmacokinetic interactions. Little is known about the possible drug interactions between caffeine and substrates of other CYP450 enzymes. In our study, methylxanthine fractions inhibited CYP3A4 in a concentration-dependent manner. Concomitant consumption of green tea with CYP3A4 substrates could increase the possibility of interactions, and this requires further clarification. The inhibition of CYP3A4 is not only due to the presence of catechin derivatives but methylxanthines may also contribute to this effect.
Methylxanthines are extensively metabolized in the liver by the cytochrome P450 (CYP450) oxidase enzyme system, mainly by demethylation, and they are excreted in human urine in the form of metabolites with less than 2% of administered caffeine being excreted unchanged 9, 10 . Caffeine is metabolized predominantly by the CYP1A2 isozyme into three dimethylxanthines, paraxanthine (>80%), theobromine and theophylline 11, 12 . Other enzymes involved in the biotransformation of methylxanthines are CYP2E1, CYP2A6, N-acetyltransferase 2 (NAT2) and xanthine oxidase (XO). Figure 1 shows the metabolism of caffeine and its major metabolites 9 .
Concomitant consumption of caffeine with CYP1A2 substrates (certain drugs used for cardiovascular, CNS, gastrointestinal, infectious, and other disorders) may lead to pharmacokinetic interactions at the CYP1A2 enzyme level. This may result in side effects or may hinder the treatment 13 . Little is known about the involvement of other enzymes that part in the metabolism of methylxanthines.
The aim of the present study was to analyse the methylxanthine fractions isolated from Pu-erh and Bancha tea leaves and to evaluate their potential to modulate the activity of human recombinant CYP3A4 in vitro.
Results
Methylxanthine fractions were extracted using an approved standard method, as described in the Materials and Methods section, and the yields from 50 g of dried Pu-erh and Bancha tea leaves were 0.521 g (or 1.04%) and 0.475 g (or 0.95%), respectively. After isolation of the methylxanthine fractions from Pu-erh and Bancha tea leaves, HPLC-UV analysis showed that both fractions contain large amounts of caffeine (84.07% and 88.11%) and very small amounts of theobromine (0.16% and 0.11%, respectively). The Pu-erh tea sample contains a negligible amount of theophylline (<0.0001%), and theophylline was not detected in the Bancha tea sample. The results are summarized in Table 1 .
The effects of methylxanthines and caffeine alone on the activity of recombinant human CYP3A4 was analysed in vitro using a Vivid ® CYP3A4 Screening Kit. The methylxanthine fractions inhibited CYP3A4 (Fig. 2 ) in a concentration-dependent manner. After analysing the results, we calculated the IC 50 values for each fraction with a 95% confidence interval (CI). The IC 50 value for the fraction isolated from Pu-erh was 1.283 mg/mL (CI: 0.9336 to 1.762 mg/mL), and that for the fraction isolated from Bancha was 1.351 mg/mL (CI: 1.119-1.631 mg/mL) ( Table 2 ). We performed time-dependent inhibition (TDI) studies to determine the kinetic parameters. The mechanism of inhibition is probably reversible, because in the kinetic time-dependent assay, we did not observe a significant decrease in the IC 50 values (Supplemental Figs 1 and 2).
To evaluate the risk of herb-drug interactions (HDI), we performed a simulation using ADMEWORKS DDI Simulator with the methylxanthines isolated from Pu-erh. For the purpose of the study, we made some assumptions. First, we assumed that the mechanism of inhibition is reversible and that it is generally competitive; therefore, according to the Michaelis-Menten Kinetic equation, Ki (the inhibition constant) would be IC 50 /2, or in our case Ki = 1.28/2 = 0.64 mg/mL. Second, because it is the major component of the fraction, we used data from pure caffeine for the general information necessary for the simulation, and we only added the Ki values for inhibition of CYP3A4. For the substrate of CYP3A4, we chose midazolam because it is eliminated mainly through CYP3A4, and it is commonly used for evaluating CYP3A4 function. We simulated a single-dose administration of 7.5 mg of midazolam with concomitant consumption of 100, 250 and 500 mg of methylxanthines. For positive control we have used ketoconazole 400 mg single dose. The results are shown in Fig. 3 . The simulations of the self-administration of 100, 250 and 500 mg methylxanthines are shown in Supplemental Fig. 3 .
Discussion
A rapid and sensitive HPLC method with UV detection was developed for the quantification of caffeine, theophylline and theobromine in Pu-erh and Bancha tea samples. Different mobile phases were used for this study 14, 15 . The best separation was obtained with isocratic elution with 90% H 2 O/10% acetonitrile. Figure 4 shows the chromatograms of the reference substances (caffeine, theophylline and theobromine) and that of Pu-erh and Bancha methylxanthines. As expected, caffeine is the main purine alkaloid in both tea fractions, accounting for 84.07% (Pu-erh) and 88.11% (Bancha), with minor differences in the percentage contents. Although in Fig. 4 
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Pu-erh is more intense than that of Bancha, that is because the Pu-erh fraction was less dilute, 2.5 mg/mL compared to 1 mg/mL, respectively. Our study has shown results similar to those reported by Sanchez JM (2017) with regard to the contents of theobromine and theophylline 16 .
In the second phase of our study, the potential of the methylxanthine fractions to modulate the activity of CYP3A4 isoenzyme was investigated. The biotransformation of drugs by the CYP3A4 enzyme is the major metabolic pathway for more than half of marketed drugs and therefore has the highest risk of drug interactions 13 . The methylxanthine fractions from Pu-erh and Bancha were used at a maximum concentration of 10 mg/mL and were serially diluted to a minimum concentration of 0.3125 mg/mL. Based on the HPLC chromatograms, the highest concentrations of caffeine in the Pu-erh and Bancha fractions were 8.4 mg/mL and 8.8 mg/mL, respectively. To assess the effects of the caffeine in the fractions, we used pure caffeine for comparison at a maximum concentration of 10 mg/mL and serially diluted it to a minimum concentration of 0.3125 mg/mL. For the positive control in the study, ketoconazole was used at a concentration of 10 µM, and this compound is known to produce 90% inhibition at this concentration. The results are shown in Figs 2 and 5.
As seen from the graphics, the methylxanthine fractions isolated from Pu-erh and Bancha tea leaves at concentrations of 10 mg/mL inhibit 79% and 72% of the activity of CYP3A4, respectively. Тheir effects are close to that of the positive control, ketoconazole. Their effects were significantly different than that of pure caffeine (p < 0.0001), and we can conclude that the effects of the fractions are not entirely due to the caffeine content. When reviewing articles published in the last few years, the inhibitory effects of the catechins contained in green tea are often mentioned. For example, in 2013 Misaka et al. 17 reported their investigation of the activity of green tea extract (GTE) and epigallocatechin-3 gallate (EGCG) on various cytochrome enzymes, including CYP3A4, using human liver and intestinal microsomes. They established IC 50 values of GTE for CYP3A (intestine) of 18.4 µg/mL and for CYP3A (liver) of 13.8 µg/mL, while those of EGCG were 31.1 (CYP3A, intestine) and 23.3 µM (CYP3A, liver). Satoh et al. 18 studied the inhibitory potential of eight catechins from green tea on CYP3A4 and other cytochromes in human liver microsomes. The strongest effects were reported against epigallocatechin-3-gallate (EGCG) and gallocatechin-3-gallate (GCG), and the IC 50 values were 23.7 and 40.8 µM, respectively.
In our study, the methylxanthine fractions isolated from Pu-erh and Bancha showed inhibitory activities on CYP3A4 with IC 50 values of 1.28 mg/mL and 1.35 mg/mL. To the best of our knowledge, the possible inhibition of the activity of cytochrome CYP3A4 by methylxanthine fractions has not been reported to date. Compared to the catechins and their IC 50 values discussed above, the effects of methylxanthines are significantly weaker. In general, we assume that the isolated methylxanthine fraction contains other components, and that the observed inhibitory effect on CYP3A4 isoenzyme is partly due to the mutual potentiation of the individual components. One study conducted by Donovan et al. 19 administered decaffeinated green tea extract to healthy volunteers, and no inhibitory effects on CYP3A4 and CYP2D6 were observed. We also investigated the possibility of inhibition against other CYP isoforms by methylxanthines, such as CYP2C9 and CYP2D6. The methylxanthines from Bancha and Pu-erh showed insignificant inhibitory activities on CYP2C9 (results not shown). Research on CYP2D6 is ongoing.
The simulation of the simultaneous administration of the different doses of methylxanthine fraction from Pu-erh with midazolam resulted in a slight change in the time course curve, while ketoconazole used for positive control caused significant changes (Fig. 3) . The calculated values of the C max ratio and AUC ratio (AUCR) are presented in Table 3 .
According to the EUFEPS (European Federation for Pharmaceutical Sciences) conference report, AUCR values ≥ 2 indicate high risks of drug-drug interactions (DDIs), AUCR values ≤ 1.25 are associated with low risks, and AUCR values between 1.25 and 2 indicate moderate risks of DDIs 20 . Therefore, in our case, the risk of clinically important herb-drug interactions (HDIs) is low. Although the changes observed in these simulations are insignificant, they are interesting, and some points have raised further questions. To validate the method, we have simulated the interaction between midazolam and ketoconazole. The presented results in Fig. 3 and Table 3 are supported by other publications 21, 22 .
In conclusion, this in vitro study indicated that green tea methylxanthines might affect the activity of liver enzymes and, in particular, CYP3A4. The modulation of CYPs is well documented for green tea and its catechin fraction; nevertheless, little is known about the involvement of methylxanthines, which are also a significant factor and contribute to the biological activity of green tea. The concomitant administration of green tea and drugs metabolized predominantly by CYP3A4 could potentially alter their elimination and the safety of these drugs. The potential for interaction with methylxanthine fractions and their contribution to the observed effects on the green tea extracts require further investigation.
Materials and Methods
Chemicals and reagents. Pu-erh and Bancha tea leaves were purchased from the local market with quality assurance. A Vivid CYP3A4 Green Screening Kit was purchased from Antisel ® (Bulgaria). Caffeine, theophylline, theobromine, ketoconazole, dimethylsulfoxide (DMSO), sodium hydroxide (NaOH, >98%), sulfuric acid, chloroform (>99%), water (high-performance liquid chromatography (HPLC) grade), acetonitrile (HPLC grade, ≥99.9%) and black Costar ® 96-well plates were purchased from Sigma-Aldrich.
Extraction of methylxanthines.
Accurately weighed amounts of Pu-erh and Bancha tea leaves (50 g) were extracted under reflux with distilled water (250 mL) for 60 min and filtered through a Buchner funnel. The aqueous extracts were acidified with 25% sulfuric acid (5 mL) and concentrated to half of their initial volume. Then, the hot solutions were filtered and extracted four times with chloroform (50 mL) in a separating funnel. The chloroform extracts (200 mL) were washed twice with 5% sodium hydroxide solution (50 mL) and twice with distilled water (50 mL). After evaporation of the chloroform, the mixture of methylxanthines was obtained, and the percentage yield was calculated 7 .
HPLC analysis. Apparatus and analytical conditions. HPLC measurements were performed with a (HPLC)
Thermo Scientific UltiMate 3000 Analytical LC System equipped with a variable UV/Vis detector (Thermo Scientific Dionex UltiMate 3000 VWD-3100 Variable Wavelength Detector/VWD). HPLC separations were performed on an analytical column (Thermo Scientific AQUASIL C18, 150 mm × 4.6 mm, 5 µm), protected by an AQUASIL C18 guard column (10 mm × 4.6 mm, 5 µm) with a flow rate of 0.8 mL/min and UV detection at 274 nm. The injection volume was 20 µL. The mobile phase was a mixture of double-distilled and filtered water with acetonitrile (90:10%, v/v) in isocratic mode. The column was maintained at 30 °C. Data analysis was performed using the Thermo Scientific ® Chromeleon ® 7.2 Chromatography Data System software.
Standard and working solutions. Standard stock solutions of caffeine (1.0 mg/mL final concentration), theophylline (1.0 mg/mL final concentration) and theobromine (0.5 mg/mL final concentration) were separately prepared by weighing each standard substance and dissolving in hot, double-distilled water at pH 8 (adjusted with 0.1 M NaOH). Subsequently, the working solutions were prepared by serial dilutions of each standard stock solution to obtain concentrations in the range of 1.0-750.0 µg/mL in water. All stock and working standard solutions were freshly prepared before analyses.
Sample preparation. The Pu-erh tea sample was prepared by weighing 50.0 mg of the powdered methylxanthine fraction, and dissolving it in hot, double-distilled water (pH 8) to a final concentration of 2.5 mg/mL. The Bancha tea sample was prepared by weighing 50.0 mg of the powdered methylxanthine fraction, and dissolving it in hot, www.nature.com/scientificreports www.nature.com/scientificreports/ double-distilled water (pH 8) to a final concentration of 1.0 mg/mL. Before the analysis, all samples were filtered through a Sartorius RC 0.45-µm membrane filter.
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Calibration curve. Calibration curves were constructed for each compound (caffeine, theophylline, and theobromine) using working standard solutions at eight concentrations in the range of 1.0 to 750.0 µg/mL. The linearity of the relationship between the peak area and the concentration was confirmed by the correlation coefficient (R 2 = 0.9995). The HPLC method was validated according to the International Conference on Harmonisation (ICH) Q2(R1) Validation of Analytical Procedures: Text and Methodology 23 . The concentrations of caffeine, theophylline and theobromine were calculated from the calibration curves.
Determination of CYP3A4 activity with Vivid P450 assay kits. The inhibitory effects of the methylxanthines isolated from Pu-erh and Bancha tea leaves and caffeine on CYP3A4 activity were determined using a Vivid ® CYP3A4 Green Screening Kit following the manufacturer's instructions 24 . Stock solutions (10 mg/mL) were prepared by diluting the powdered methylxanthine fractions and caffeine (reference substance) in hot, double-distilled water. The samples in each well were mixed with a master pre-mix, containing reaction buffer, CYP450 BACULOSOMES ® reagent and the regeneration system, which contained glucose-6-phosphate and glucose-6-phosphate dehydrogenase. The mixture was incubated at room temperature for 20 min. Following the incubation, the CYP enzyme-specific substrate (di(benzyloxymethoxy)fluorescein (DBOMF, Vivid green substrate for CYP3A4)) and NADP + were added, and the mixture was maintained at room temperature for 30 min. The reaction was stopped by the addition of 10 µM ketoconazole, and the enzyme activity was evaluated by measuring the fluorescence at excitation/emission wavelengths of 485/528 nm (BioTek Synergy 2).
Time-dependent inhibition (TDI).
The general conditions for the conducted experiments are the same as those described above. The reaction kinetics were determined using the kinetic measurement protocol described in the manufacturer 24 and exemplified in a study by Fairman et al. 25 and this process involves fluorescence measurements taken at 5 min intervals for 30 min.
Drug-herb interaction (DHI) simulation. ADMEWORKS DDI Simulator version 2.4. (Fudjitsu Kyushu
System Limited) was used to evaluate the potential for drug-herb interactions 26 . The Simulator platform provides physicochemical and pharmacokinetic data for various CYP substrates. For the purpose of the study, we chose midazolam as the CYP3A4 substrate. The simulations were conducted using the basic PBPK (physiologically based pharmacokinetic) mechanistic model (Supplemental Fig. 4 ). The input parameters of MXP are shown in Table 4 and those of midazolam and ketoconazole are presented in Supplemental Tables 1 and 2 www.nature.com/scientificreports www.nature.com/scientificreports/ To build the plots and to calculate the IC 50 values and 95% confidence intervals, we used a four-parameter logistic curve (4PL) generated in GraphPad Prism version 8.0.1 (GraphPad Software, USA), with the equation: Y = Bottom + (Top-Bottom)/(1 + 10^((LogIC50-X)*HillSlope)). The other results are expressed as percentages or means ± standard deviation (Mean ± SD) and were determined using Microsoft Excel 2013. Differences between groups were analysed using ANOVA. For every different concentration, we used six replicates, and a P value < 0.05 was considered statistically significant.
